Roundhill GLP-1 & Weight Loss ETF
OZEM
#2852
ETF rank
โ‚ฌ45.41 M
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
27,36ย โ‚ฌ
Share price
1.12%
Change (1 day)
38.34%
Change (1 year)
Roundhill GLP-1 & Weight Loss ETF (OZEM) provides exposure to companies developing innovative GLP-1 and other weight loss therapies.

Roundhill GLP-1 & Weight Loss ETF - Holdings

Etf holdings as of April 15, 2026Number of holdings: 28

Full holdings list

Weight %NameTickerShares Held
15.77%
Eli Lilly & CoLLY9003
13.72%
Novo Nordisk A/SNVO183834
7.12%
Pfizer IncPFE138419
5.63%
Viking Therapeutics IncVKTX83569
5.07%
Innovent Biologics Inc1801 HK242500
4.75%
Ascletis Pharma Inc1672 HK1133000
3.98%
Roche Holding AGROP SW5146
3.84%
Amgen IncAMGN5762
3.81%
AstraZeneca PLCAZN9819
3.62%
Zealand Pharma A/SZEAL DC40685
3.59%
Hanmi Pharm Co Ltd128940 KS5593
3.34%
Chugai Pharmaceutical Co Ltd4519 JP32800
3.18%
Regeneron Pharmaceuticals IncREGN2218
3.17%
Shanghai Fosun Pharmaceutical Group Co Ltd2196 HK662500
2.88%
CSPC Pharmaceutical Group Ltd1093 HK1298000
2.56%
Structure Therapeutics IncGPCR25378
2.29%
United Laboratories International Holdings Ltd/The3933 HK954000
2.29%
Gubra A/SGUBRA DC22723
2.13%
MBX Biosciences IncMBX34264
1.88%
Gilead Sciences IncGILD7043
1.40%
Rhythm Pharmaceuticals IncRYTM8463
1.30%
Shionogi & Co Ltd4507 JP32700
1.05%
Biohaven LtdBHVN53094
1.05%
First American Government Obligations Fund 12/01/2031FGXXX553171.68
0.46%
WaVe Life Sciences LtdWVE32778
0.42%
Corbus Pharmaceuticals Holdings IncCRBP22131
0.19%
Cash & OtherCash&Other99076.53
-0.52%
SWISS FRANCCHF-215321.29